About RIGEL PHARMACEUTICALS INC
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and providing novel therapies to improve the lives of patients with hematologic disorders and cancer. The company has several FDA-approved treatments for specific conditions.
Discovery and development of novel therapiesClinical trials for hematologic disorders and cancerFDA-approved drug development (e.g., TAVALISSE, REZLIDHIA, Gavreto)
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATM | Department of Health and Human Services | $750K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RIGEL PHARMACEUTICALS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.